Literature DB >> 1092275

Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

J Webb, K Whaley, R N MacSween, G Nuki, W C Dick, W W Buchanan.   

Abstract

Inter-relationships of biochemical and immunological tests of liver function have been studied in a prospective study of 216 patients with rheumatoid arthritis (RA), 32 patients with Sjogren's syndrome, and 27 patients with the sicca syndrome, and these results have been compared with those obtained 289 patients with osteoarthrosis or with a form of seronegative polyarthropathy. In general the prevalence of abnormalities in serum alkaline phosphatase, bromsulphthalein excretion, smooth muscle antibody, and mitochondrial antibody in the former three groups was higher than in patients with osteoarthrosis. Patients with Sjogren's syndrome with RA had a higher prevalence of abnormalities of bromsulphthalein excretion, salivary duct antibody than patients with the sicca syndrome. Patients with RA had a higher pervalence of rheumatoid factor than those with the sicca syndrome. Patients with a positive smooth muscle or mitochondrial antibody were found to have a higher prevalence of hepatomegaly and splenomegaly, of abnormal liver function tests, of other autoantibodies, and of histological abnromalitis of liver than those in whom these tests were negative.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092275      PMCID: PMC1006348          DOI: 10.1136/ard.34.1.70

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  54 in total

1.  Variations in the morphological patterns of "autoimmune" nuclear fluorescence.

Authors:  J S BECK
Journal:  Lancet       Date:  1961-06-03       Impact factor: 79.321

2.  Liver function in relation to possible abnormalities of steroid metabolism in rheumatoid arthritis.

Authors:  L M ROY; F W WIGZELL; R DEMERS; R J SINCLAIR; J J DUTHIE; S M ATHERDEN; G F MARRIAN
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

3.  The liver in rheumatoid arthritis.

Authors:  A M LEFKOVITS; I J FARROW
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

4.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

5.  Rheumatoid arthritis and polyarteritis nodosa.

Authors:  J BALL
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

6.  Liver biopsy in rheumatoid arthritis.

Authors:  E R MOVITT; A E DAVIS
Journal:  Am J Med Sci       Date:  1953-11       Impact factor: 2.378

7.  Thymol reaction in rheumatoid arthritis.

Authors:  K KALBAK
Journal:  Ann Rheum Dis       Date:  1951-06       Impact factor: 19.103

8.  5-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease.

Authors:  M J Kendall; A M Bold; M Farr; C F Hawkins
Journal:  Lancet       Date:  1971-11       Impact factor: 79.321

9.  Arteritis, myocardial infarction, and rheumatoid arthritis.

Authors:  I Karten
Journal:  JAMA       Date:  1969-12-01       Impact factor: 56.272

10.  A clinical and pathological study of sixteen cases of rheumatoid arthritis with extensive visceral involvement ('rheumatoid disease').

Authors:  B CRUICKSHANK; R J SINCLAIR
Journal:  Q J Med       Date:  1956-07
View more
  23 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Anaesthesia management for acute appendicitis in cases with Sjogren's syndrome accompanying autoimmune hepatitis.

Authors:  Ismail Demirel; Ayse Belin Ozer; Mustafa K Bayar; Omer L Erhan
Journal:  BMJ Case Rep       Date:  2013-04-30

3.  Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica.

Authors:  A Doube; J Davies; M Davis; P J Maddison
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

4.  Arthritis and primary biliary cirrhosis.

Authors:  P Mills; R N MacSween; G Watkinson
Journal:  Br Med J       Date:  1977-11-05

5.  Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.

Authors:  O S Als; C Christiansen; C Hellesen
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Serum concentration of vitamin D metabolites in rheumatoid arthritis.

Authors:  O S Als; B Riis; C Christiansen
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

7.  Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis.

Authors:  R J Spooner; D H Smith; D Bedford; P R Beck
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

8.  Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity.

Authors:  S Aida
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

9.  Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis.

Authors:  L Fernandes; S Sullivan; I G McFarlane; B M Wojcicka; T W Warnes; A L Eddleston; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

Review 10.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.